Legal & General Group Plc Lowers Holdings in Healthpeak Properties, Inc. $DOC

Legal & General Group Plc decreased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 18.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,428,632 shares of the real estate investment trust’s stock after selling 1,197,609 shares during the quarter. Legal & General Group Plc’s holdings in Healthpeak Properties were worth $116,173,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. State Street Corp grew its holdings in Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after purchasing an additional 2,438,278 shares during the period. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after purchasing an additional 123,274 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock worth $294,244,000 after purchasing an additional 1,648,012 shares during the period. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC stock opened at $21.23 on Friday. The firm has a market cap of $14.64 billion, a price-to-earnings ratio of 60.67, a PEG ratio of 2.35 and a beta of 1.01. The firm has a 50-day simple moving average of $21.52 and a two-hundred day simple moving average of $19.17. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.95. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same period last year, the business earned $0.46 EPS. The company’s revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

Wall Street Analysts Forecast Growth

DOC has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, August 19th. BMO Capital Markets boosted their price objective on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. JPMorgan Chase & Co. upped their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Citigroup increased their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. Finally, Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a report on Monday, May 11th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $21.66.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.